Content deleted Content added
m Task 18 (cosmetic): eval 11 templates: del empty params (8×); |
→Steps of mechanism: rm repetition |
||
(39 intermediate revisions by 26 users not shown) | |||
Line 1:
{{Short description|Process of preventing and stopping bleeding}}{{Distinguish|homeostasis}}
In [[biology]], '''
* [[vasoconstriction]]
* temporary blockage of a hole in a damaged blood vessel by a [[platelet plug]]
* [[coagulation|blood coagulation]] (formation of [[fibrin]] clots)
Coagulation, the changing of blood from a liquid to a [[gel]] which forms the fibrin clots, is essential to hemostasis. Intact blood vessels moderate blood's tendency to form [[thrombus|clots]]. The [[endothelium|endothelial]] cells of intact vessels prevent blood clotting with a heparin-like molecule and [[thrombomodulin]], and prevent platelet aggregation with [[nitric oxide]] and [[prostacyclin]]. When endothelium of a blood vessel is damaged, the endothelial cells stop secretion of coagulation and aggregation inhibitors and instead secrete [[von Willebrand factor]], which initiates the maintenance of hemostasis after injury. These processes seal the injury or hole until tissues are healed.
==Etymology and pronunciation==
The word ''hemostasis'' ({{IPAc-en|ˌ|h|iː|m|oʊ-|ˈ|s|t|eɪ|s|ᵻ|s|}},{{refn|{{MerriamWebsterDictionary|
==Steps of mechanism==
{{Further|Coagulation}}
[[File:Thrombocyteaggregation.jpg|thumb|Aggregation of [[
Hemostasis occurs when blood is present outside of the body or blood vessels. It is the innate response for the body to stop bleeding and loss of blood. During hemostasis three steps occur in a rapid sequence. Vascular spasm is the first response as the blood vessels constrict to allow less blood to be lost. In the second step, platelet plug formation, [[platelets]] stick together to form a temporary seal to cover the break in the vessel wall. The third and last step is called coagulation or blood clotting. Coagulation reinforces the platelet plug with fibrin threads that act as a "molecular glue".<ref name=marieb/> Platelets are a large factor in the hemostatic process. They allow for the creation of the "platelet plug" that forms almost directly after a blood vessel has been ruptured. Within seconds of a blood vessel's epithelial wall being disrupted, platelets begin to adhere to the sub-[[endothelium]] surface. It takes approximately sixty seconds until the first fibrin strands begin to intersperse among the wound. After several minutes the platelet plug is completely formed by fibrin.<ref>Boon, G. D. "An Overview of Hemostasis." Toxicologic Pathology 21.2 (1993):
# '''[[Vascular spasm]]
# '''Platelet plug formation
# '''Clot formation
==Types==
Hemostasis can be achieved in various other ways if the body cannot do it naturally (or needs help) during surgery or medical treatment. When the body is under shock and stress, hemostasis is harder to achieve. Though natural hemostasis is most desired, having other means of achieving this is vital for survival in many emergency settings. Without the ability to stimulate hemostasis the risk of [[hemorrhaging]] is great. During surgical procedures, the types of hemostasis listed below can be used to control bleeding while avoiding and reducing the risk of tissue destruction. Hemostasis can be achieved by [[chemical agents|chemical agent]] as well as mechanical or physical agents. Which hemostasis type used is determined based on the situation.<ref name=roshni>{{cite journal | author = Kulkarni Roshni | year = 2004 | title = Alternative and Topical Approaches to Treating the Massicely Bleeding Patient | url =
[[Developmental Haemostasis]] refers to the differences in the haemostatic system between children and adults.
Line 23 ⟶ 28:
Some main types of hemostasis used in emergency medicine include:
* '''Chemical/topical'''
* '''Direct pressure or [[pressure dressing]]''' – This type of hemostasis approach is most commonly used in situations where proper medical attention is not available. Putting pressure and/or dressing to a bleeding wound slows the process of blood loss, allowing for more time to get to an emergency medical setting. Soldiers use this skill during combat when someone has been injured because this process allows for blood loss to be decreased, giving the system time to start coagulation.<ref>{{cite journal |author1=Smith Shondra L. |author2=Belmont John M. |author3=Casparian J. Michael | year = 1999 | title = Analysis Of Pressure Achieved By Various Materials Used For Pressure Dressings | journal = Dermatologic Surgery | volume = 25 | issue = 12| pages = 931–934 | doi=10.1046/j.1524-4725.1999.99151.x|pmid=10594624 }}</ref>
▲* '''Chemical/topical'''- This is a topical agent often used in surgery settings to stop bleeding. Microfibrillar [[collagen]] is the most popular choice among surgeons [recent source?] because it attracts the patient's natural platelets and starts the blood clotting process when it comes in contact with the platelets. This topical agent requires the normal hemostatic pathway to be properly functional.<ref>Aldo Moraci, et al. "The Use Of Local Agents: Bone Wax, Gelatin, Collagen, Oxidized Cellulose." ''European Spine Journal'' 2004; 13.: S89-S96.</ref>
* '''
* '''
==Disorders==
The body's hemostasis system requires careful regulation in order to work properly. If the blood does not clot sufficiently, it may be due to bleeding disorders such as [[hemophilia]] or [[immune thrombocytopenia]]; this requires careful investigation. Over-active clotting can also cause problems; [[thrombosis]], where blood clots form abnormally, can potentially cause [[embolisms]], where blood clots break off and subsequently become lodged in a vein or artery.{{cn|date=November 2021}}
Hemostasis disorders can develop for many different reasons. They may be [[congenital]], due to a deficiency or defect in an individual's platelets or clotting factors. A number of disorders can be acquired as well, such as in [[HELLP syndrome]], which is due to pregnancy, or [[Hemolytic-uremic syndrome]] (HUS), which is due to ''E. coli'' toxins.
==History of artificial hemostasis==
The process of preventing blood loss from a vessel or organ of the body is referred to as hemostasis. The term comes from the [[Ancient Greek]] roots "heme" meaning blood, and "stasis" meaning halting; Put together means the "halting of the blood".<ref name=marieb>{{cite book|last1=Marieb|first1=Elaine Nicpon|first2=Katja|last2=Hoehn|title=Human Anatomy & Physiology|edition=8th|location=San Francisco|publisher=Benjamin Cummings|year=2010|pages=
The origin of hemostasis dates back as far as ancient Greece; first referenced to being used in the [[Battle of Troy]]. It started with the realization that excessive bleeding inevitably equaled death. Vegetable and mineral styptics were used on large wounds by the Greeks and Romans until the takeover of Egypt around 332BC by Greece. At this time many more advances in the general medical field were developed through the study of Egyptian [[mummification]] practice, which led to greater knowledge of the hemostatic process. It was during this time that many of the veins and arteries running throughout the human body were found and the directions in which they traveled. Doctors of this time realized if these were plugged, blood could not continue to flow out of the body. Nevertheless, it took until the invention of the printing press during the fifteenth century for medical notes and ideas to travel westward, allowing for the idea and practice of hemostasis to be expanded.<ref name=weis>{{Cite journal|title=Wies, C. H. "The History of Hemostasis." Yale Journal of Biology and Medicine
==Research==
There is currently a great deal of research being conducted on hemostasis. The most current research is based on genetic factors of hemostasis and how it can be altered to reduce the cause of [[genetic disorders]] that alter the natural process hemostasis.<ref>{{cite journal |last1=Rosen |first1=Elliot D. |last2=Xuei |first2=Xiaoling |last3=Suckow |first3=Mark |last4=Edenberg |first4=Howard |date=2006 |title=Searching for hemostatic modifier genes affecting the phenotype of mice with very low levels of FVII |journal=Blood Cells, Molecules and Diseases |volume=36 |issue=2 |pages=131–134 |doi=10.1016/j.bcmd.2005.12.037|pmid=16524747 }}</ref>
[[Von Willebrand disease]] is associated with a defect in the ability of the body to create the platelet plug and the fibrin mesh that ultimately stops the bleeding. New research is concluding that the von Willebrand disease is much more common in adolescence. This disease negatively hinders the natural process of Hemostasis causing excessive bleeding to be a concern in patients with this disease. There are complex treatments that can be done including a combination of therapies, [[estrogen]]-[[progesterone]] preparations, [[desmopressin]], and Von Willebrand factor concentrates. Current research is trying to find better ways to deal with this disease; however, much more research is needed in order to find out the effectiveness of the current treatments and if there are more operative ways to treat this disease.<ref name="mikhail">{{cite journal |last1=Mikhail |first1=Sameh |last2=Kouides |first2=Peter |date=December 2010 |title=von Willebrand Disease in the Pediatric and Adolescent Population |journal=Journal of Pediatric
==See also==
* Blood tests:
* [[Prothrombin time]]
* [[Partial thromboplastin time]]
==References==
Line 55 ⟶ 59:
{{Blood physiology}}
{{Authority control}}
[[Category:Hematology]]
|